The ASAP trial sets new perspectives on international therapy standards: High-dose chemotherapy is not always necessary before transplantation in cases of acute myeloid leukemia (AML). This means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback